Henry Schein (HSIC) Updates FY19 Earnings Guidance

Henry Schein (NASDAQ:HSIC) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share guidance of $3.38-3.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.42. Henry Schein also updated its FY 2019 guidance to $3.38-3.50 EPS.

Several analysts have issued reports on HSIC shares. Zacks Investment Research upgraded shares of Henry Schein from a hold rating to a buy rating and set a $78.00 target price on the stock in a research note on Monday, May 13th. BidaskClub cut shares of Henry Schein from a hold rating to a sell rating in a research note on Tuesday, May 7th. Wolfe Research initiated coverage on shares of Henry Schein in a research note on Thursday. They issued an underperform rating on the stock. Guggenheim initiated coverage on shares of Henry Schein in a research report on Wednesday, April 17th. They set a buy rating and a $72.00 price objective on the stock. Finally, Robert W. Baird restated a neutral rating on shares of Henry Schein in a research report on Monday, March 25th. Seven research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus price target of $74.27.

NASDAQ HSIC traded down $0.67 during trading hours on Friday, reaching $64.46. 1,008,407 shares of the company’s stock traded hands, compared to its average volume of 1,808,309. Henry Schein has a 52-week low of $56.58 and a 52-week high of $91.35. The stock has a market cap of $9.75 billion, a P/E ratio of 15.61, a price-to-earnings-growth ratio of 2.29 and a beta of 0.89. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.65 and a quick ratio of 0.93.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, May 7th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.76 by $0.04. Henry Schein had a net margin of 4.10% and a return on equity of 18.35%. The business had revenue of $2.36 billion during the quarter, compared to analysts’ expectations of $2.36 billion. During the same period in the previous year, the company earned $0.95 earnings per share. The business’s revenue for the quarter was up 3.8% compared to the same quarter last year. Research analysts expect that Henry Schein will post 3.45 earnings per share for the current fiscal year.

In other news, Director Philip A. Laskawy sold 1,084 shares of the business’s stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $59.86, for a total transaction of $64,888.24. Following the completion of the transaction, the director now directly owns 32,899 shares of the company’s stock, valued at $1,969,334.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.06% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: This article was first reported by Mayfield Recorder and is the sole property of of Mayfield Recorder. If you are reading this article on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://mayfieldrecorder.com/2019/06/01/henry-schein-hsic-issues-fy19-earnings-guidance.html.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More: What is the Difference Between Common Shares and Convertible Shares?

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.